BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29242857)

  • 1. Biphasic drug release from electrospun polyblend nanofibers for optimized local cancer treatment.
    Kuang G; Zhang Z; Liu S; Zhou D; Lu X; Jing X; Huang Y
    Biomater Sci; 2018 Jan; 6(2):324-331. PubMed ID: 29242857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine A Loaded Electrospun Poly(D,L-Lactic Acid)/Poly(Ethylene Glycol) Nanofibers: Drug Carriers Utilizable in Local Immunosuppression.
    Sirc J; Hampejsova Z; Trnovska J; Kozlik P; Hrib J; Hobzova R; Zajicova A; Holan V; Bosakova Z
    Pharm Res; 2017 Jul; 34(7):1391-1401. PubMed ID: 28405914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core-shell poly(lactide-co-ε-caprolactone)-gelatin fiber scaffolds as pH-sensitive drug delivery systems.
    Sang Q; Li H; Williams G; Wu H; Zhu LM
    J Biomater Appl; 2018 Mar; 32(8):1105-1118. PubMed ID: 29295656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrospun PLA/MWCNTs composite nanofibers for combined chemo- and photothermal therapy.
    Zhang Z; Liu S; Xiong H; Jing X; Xie Z; Chen X; Huang Y
    Acta Biomater; 2015 Oct; 26():115-23. PubMed ID: 26260417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.
    Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y
    Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalization of electrospun poly(caprolactone) fibers for pH-controlled delivery of doxorubicin hydrochloride.
    Jassal M; Sengupta S; Bhowmick S
    J Biomater Sci Polym Ed; 2015; 26(18):1425-38. PubMed ID: 26406285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-preferential sustained drug release enhances antitumor activity of block copolymer micelles.
    Ponta A; Bae Y
    J Drug Target; 2014 Aug; 22(7):619-28. PubMed ID: 24766185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds.
    Ardeshirzadeh B; Anaraki NA; Irani M; Rad LR; Shamshiri S
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():384-90. PubMed ID: 25579938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel electrospun nanofibrous matrices prepared from poly(lactic acid)/poly(butylene adipate) blends for controlled release formulations of an anti-rheumatoid agent.
    Siafaka PI; Barmbalexis P; Bikiaris DN
    Eur J Pharm Sci; 2016 Jun; 88():12-25. PubMed ID: 27039136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of cisplatin-loaded mucoadhesive nanofibers for local chemotherapy of cervical cancers in mice.
    Zong S; Wang X; Yang Y; Wu W; Li H; Ma Y; Lin W; Sun T; Huang Y; Xie Z; Yue Y; Liu S; Jing X
    Eur J Pharm Biopharm; 2015 Jun; 93():127-35. PubMed ID: 25843238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Star poly(ε-caprolactone)-based electrospun fibers as biocompatible scaffold for doxorubicin with prolonged drug release activity.
    Bala Balakrishnan P; Gardella L; Forouharshad M; Pellegrino T; Monticelli O
    Colloids Surf B Biointerfaces; 2018 Jan; 161():488-496. PubMed ID: 29128835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of fabrication conditions of acrylate-based hydrogel formulations for doxorubicin release and efficacy test for hepatocellular carcinoma cell.
    Bayramoglu G; Gozen D; Ersoy G; Ozalp VC; Akcali KC; Arica MY
    J Biomater Sci Polym Ed; 2014; 25(7):657-78. PubMed ID: 24580096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel controlled drug delivery system for multiple drugs based on electrospun nanofibers containing nanomicelles.
    Hu J; Zeng F; Wei J; Chen Y; Chen Y
    J Biomater Sci Polym Ed; 2014; 25(3):257-68. PubMed ID: 24160558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temozolomide Conjugated Carbon Quantum Dots Embedded in Core/Shell Nanofibers Prepared by Coaxial Electrospinning as an Implantable Delivery System for Cell Imaging and Sustained Drug Release.
    Shamsipour M; Mansouri AM; Moradipour P
    AAPS PharmSciTech; 2019 Jul; 20(7):259. PubMed ID: 31332574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of bacteriocins from nanofibers prepared with combinations of poly(d,l-lactide) (PDLLA) and poly(ethylene oxide) (PEO).
    Heunis T; Bshena O; Klumperman B; Dicks L
    Int J Mol Sci; 2011; 12(4):2158-73. PubMed ID: 21731433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled delivery of bPEI-niclosamide complexes by PEO nanofibers and evaluation of its anti-neoplastic potentials.
    Kumar SU; Gopinath P
    Colloids Surf B Biointerfaces; 2015 Jul; 131():170-81. PubMed ID: 25988281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supramolecular assembly of poly(β-cyclodextrin) block copolymer and benzimidazole-poly(ε-caprolactone) based on host-guest recognition for drug delivery.
    Gao Y; Li G; Zhou Z; Guo L; Liu X
    Colloids Surf B Biointerfaces; 2017 Dec; 160():364-371. PubMed ID: 28963957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrospun nanofibrous mats containing quaternized chitosan and polylactide with in vitro antitumor activity against HeLa cells.
    Ignatova MG; Manolova NE; Toshkova RA; Rashkov IB; Gardeva EG; Yossifova LS; Alexandrov MT
    Biomacromolecules; 2010 Jun; 11(6):1633-45. PubMed ID: 20469930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local in vitro delivery of rapamycin from electrospun PEO/PDLLA nanofibers for glioblastoma treatment.
    Wang B; Li H; Yao Q; Zhang Y; Zhu X; Xia T; Wang J; Li G; Li X; Ni S
    Biomed Pharmacother; 2016 Oct; 83():1345-1352. PubMed ID: 27580454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.